上海市锦天城律师事务所 关于安徽德力日用玻璃股份有限公司 2025 年第二次临时股东大会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：02120511000 传真：02120511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于安徽德力日用玻璃股份有限公司 2025 年第二次临时股东大会的 法律意见书 致：安徽德力日用玻璃股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受安徽德力日用玻璃股份 有限公司（以下简称"公司"）的委托，根据《中华人民共和国公司法》（以下 简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、 《上市公司股东会规则》（以下简称"《股东会规则》"）等法律、法规、规范 性文件和《安徽德力日用玻璃股份有限公司章程》（以下简称"《公司章程》"） 的有关规定，指派律师列席公司 2025 年第二次临时股东大会（以下简称"本次 股东大会"），对本次股东大会相关事项进行见证，并依法出具本法律意见书。 本法律意见书仅就本次股东大会的召集和召开程序、出席本次股东大会人员 的资格、召集 ...

证券代码：002571 证券简称：德力股份 公告编号：2025-034 安徽德力日用玻璃股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、重要提示 1、为尊重中小投资者利益，提高中小投资者对公司股东大会决议的重大事 项的参与度，本次股东大会采用中小投资者单独计票,并就中小投资者的投票结 果进行了单独计票。中小投资者是指除上市公司董事、监事、高级管理人员，或 单独或合计持有上市公司5%以上股份的股东以外的其他股东。 2、对本次会议投反对票的中小投资者可以通过下列联系方式同公司取得联 系，公司将认真研究中小投资者意见，提高决策的科学性，民主性。 互动邮箱：deli@deliglass.com 互动电话：0550-6678809 3、本次会议上无否决或修改议案的情况。 4、本次会议上没有新提案提交表决。 5、"公司"或"本公司"均指安徽德力日用玻璃股份有限公司 二、会议召开情况 1、会议通知情况: 公司董事会于2025年7月25日在《证券时报》和巨潮资讯 网上刊登了《关于召开2025年第二次临时股东大会的公告》 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300993 | 玉马科技 | 19.09 | 19.99% | 23.22万 | | 4.23亿 | | 603216 | 梦天家居 | 14.87 | 9.99% | 5.31万 | | 7770.43万 | | 002571 | 德力股份 | 6.78 | 7.79% | 32.89万 | | 2.21亿 | | 603848 | 好太太 | 20.41 | 6.64% | 7.20万 | | 1.44亿 | | 300749 | 顶固集创 | 9.31 | 4.84% | 9.25万 | | 8463.00万 | | 001221 | 悍高集团 | 46.95 | 4.29% | 9.99万 | | 4.63亿 | | 301227 | 未應窗 | 31.48 | 3.89% | 2.65万 | | 8141.66万 | | 603709 | 中源家居 | 15.22 | 3.61% | 4.31万 | | 6514.74万 ...

Group 1 - The stock price of Delixi Co., Ltd. closed at 6.29 yuan on August 8, down 0.63% from the previous trading day [1] - The trading volume on that day was 124,900 hands, with a transaction amount of 78 million yuan [1] - Delixi Co., Ltd. is primarily engaged in the research, production, and sales of household light industrial products, covering multiple categories [1] Group 2 - The company plans to invest in a new project in Egypt [1] - Delixi Co., Ltd. indicated on its interactive platform that the number of shareholders will be disclosed in the periodic report [1] - On August 8, the net inflow of main funds was 1.9972 million yuan, with a cumulative net inflow of 35.4884 million yuan over the past five trading days [1]

Core Viewpoint - The company, Delixi Co., Ltd. (002571), announced plans to invest in a new project in Egypt as stated in their response to investor inquiries on August 8 [1] Group 1 - The company is planning to establish a new project in Egypt [1] - The announcement was made through the company's interaction platform, indicating transparency in communication with investors [1] - Investors are encouraged to refer to the company's previously disclosed announcements for more details [1]

Group 1 - The company, Delixi Co., announced on August 8 that it will disclose the number of shareholders in its periodic reports [2]

金融界消息 截至2025年7月31日收盘，德力股份（002571）报收于5.86元，下跌2.66%，换手率3.09%， 成交量9.22万手，成交金额5466.32万元。 天眼查商业履历信息显示，安徽德力日用玻璃股份有限公司，成立于2002年，位于滁州市，是一家以从 事非金属矿物制品业为主的企业。企业注册资本39195.07万人民币，实缴资本6310万人民币。公司法定 代表人为施卫东。 通过天眼查大数据分析，安徽德力日用玻璃股份有限公司共对外投资了23家企业，参与招投标项目326 次，知识产权方面有商标信息73条，专利信息496条，此外企业还拥有行政许可58个。 来源：金融界 资金流向方面，今日主力资金净流出1031.12万元，占比成交额18.86%。其中，超大单净流出353.40万 元、占成交额6.47%，大单净流出677.72万元、占成交额12.4%，中单净流出流入667.58万元、占成交额 12.21%，小单净流入363.54万元、占成交额6.65%。 德力股份最新一期业绩显示，截至2025一季报，公司营业总收入3.72亿元、同比增长1.56%，归属净利 润2825.66万元，同比减少599.96%，扣非 ...

Group 1 - Anhui Construction won a joint bid for the Chongqing Rongchang to Sichuan Zigong expressway project, with a total estimated investment of 3.614 billion yuan and a construction period of 3 years [1] - Hongfa Co. reported a net profit of 964 million yuan for the first half of 2025, a year-on-year increase of 14.19%, with revenue of 8.347 billion yuan, up 15.43% [1][2] - Lujiazui's net profit for the first half of 2025 was 815 million yuan, a decrease of 7.87%, despite a revenue increase of 33.91% to 6.598 billion yuan [3] - Enhua Pharmaceutical achieved a net profit of 700 million yuan, up 11.38%, with revenue of 3.010 billion yuan, an increase of 8.93% [4][5] - China CNR signed several major contracts totaling approximately 32.92 billion yuan, covering various sectors including urban rail vehicles and wind power equipment [6] - WanTong Intelligent signed an exclusive sales and cooperation agreement in the embodied intelligence field, gaining global sales rights for specific chip-based products [7][8] Group 2 - Liansheng Technology's subsidiary received a government subsidy of 13.5 million yuan, accounting for 12.24% of the company's latest audited net profit [9] - Guobang Pharmaceutical reported a net profit of 456 million yuan, a year-on-year increase of 12.60%, with revenue of 3.026 billion yuan, up 4.63% [10] - Baotai expects a net loss of 110 to 140 million yuan for the first half of 2025, a reduction in loss compared to the previous year [11] - Sains expects a net profit decrease of 57.53% to 60.13%, with projected revenue growth of 15.17% to 23.59% [12] - Nanya New Materials anticipates a net profit of 80 to 95 million yuan for the first half of 2025, an increase compared to the previous year [13] - Tian Pharmaceutical's subsidiary passed the consistency evaluation for a peritoneal dialysis solution [14] Group 3 - Shede Liquor announced the resignation of director Ni Qiang due to work reasons [15] - Greentown Water plans to transfer assets and liabilities of its ASEAN subsidiary to improve resource allocation [16] - Beibu Gulf Port's subsidiary signed an associated transaction contract worth 11.199 million yuan [17] - Beibu Gulf Port announced multiple resignations of directors and executives [18] - Jidian Co. reported the resignation of its deputy general manager due to work changes [19] - Wanhua Chemical's industrial park in Fujian resumed production after maintenance [20] Group 4 - Shanghai Pharmaceuticals received approval for a clinical trial of a new indication for its B019 injection [21] - Jianbang Co. reported a net profit of 69.66 million yuan, a decrease of 27.72%, with revenue of 307 million yuan, down 15.37% [23] - Jianbang Co. plans to use up to 400 million yuan of idle funds for cash management [25] - Wanfu Bio's subsidiary obtained multiple medical device registrations [28] - Hunan Tianyan announced a change in its controlling shareholder to China Chang'an Automobile Group [29][30] - Xizhuang Co. plans to establish a joint venture for sustainable aviation fuel [32]

Investment Overview - Anhui Delixi Daily Glass Co., Ltd. approved the establishment of two wholly-owned subsidiaries: Delixi (Beihai) Glass Co., Ltd. and Delixi Pharmaceutical Glass Co., Ltd., with an investment of 100 million yuan each [1] - The company has decided to terminate the investment projects for both subsidiaries due to market changes and strategic considerations [2][3] Termination Reasons - Both projects have not commenced substantial construction, and the expected returns have significantly changed, leading to increased uncertainty [2] - The company has also canceled plans for a private placement to raise funds for the Delixi Pharmaceutical Glass project due to market conditions [2] Investment Status and Future Plans - As of June 30, 2025, the investment status is as follows: - Beihai Company: Registered capital of 100 million yuan, invested 102.787 million yuan, with a loss of 25.39 million yuan - Delixi Pharmaceutical Glass: Registered capital of 50 million yuan, fully invested with no profit [2] - The Beihai Company will sign agreements with the local government to repurchase land at the original auction price of 95 million yuan by October 30, 2025 [2] Impact of Termination - The termination of these projects is a strategic adjustment based on market changes and will not adversely affect the company's operations or harm minority shareholders' interests [3]

Transaction Overview - The company plans to sell 100% equity of its wholly-owned subsidiary, De Rui Mining, for a total price of 135 million yuan to Fengyang Mining Investment Holding Co., Ltd. This transaction aims to focus on the company's main business development and improve asset utilization efficiency [1][2] - The transaction does not involve related party transactions and does not constitute a major asset restructuring as defined by relevant regulations, thus no approval from regulatory authorities is required [2] Financial Summary of De Rui Mining - As of April 30, 2025, De Rui Mining's total assets were approximately 168.15 million yuan, total liabilities were about 111.75 million yuan, and net assets were around 168.15 million yuan. The company reported a net profit of approximately 1.45 million yuan for the same period [2] - The financial data indicates that De Rui Mining had no operating income as of the reporting date [2] Valuation and Pricing - The transfer price of 135 million yuan is based on an asset appraisal report from Walker (Beijing) International Asset Appraisal Co., Ltd., which valued De Rui Mining's total equity at approximately 155.50 million yuan as of April 30, 2025 [8][9] - The valuation utilized the asset-based approach, with a decrease in the value of non-current assets and total assets compared to their book values [8][9] Transaction Agreement Details - The agreement stipulates that the buyer will pay 40% of the transfer price (54 million yuan) within 10 working days after the agreement is signed, and the remaining 60% (81 million yuan) within 60 days [10] - The agreement includes provisions for the handling of undistributed profits and tax responsibilities related to the transaction [10][11] Impact on the Company - This transaction is expected to optimize resource allocation, enhance cash flow for the main business, and align with the company's strategic development plans. It will not affect the company's normal production and operations, nor will it involve personnel placement or debt restructuring [12] - The transaction is anticipated to result in an estimated loss of approximately 6.5 million yuan, but it is not expected to have a significant adverse impact on the company's financial status or operations [12]